What we do
Smiths Medical is dedicated to supporting healthcare professionals and providers to enhance patient outcomes and help save lives. We develop high quality, specialised medical devices and consumables that are found in hospitals, ambulances, homes and specialty care environments. They are used during critical and intensive care, surgery, post-operative care and for support in managing chronic illnesses. In hospitals around the world, doctors treat patients with confidence using our trusted medical devices designed to administer the safest and most effective treatment for a range of medical conditions.
A global presence
We sell our products in over 120 countries and have operations in over 30. Smiths Medical’s expertise provide lifesaving solutions for the world’s healthcare markets.
£209m2017 headline operating profit
- Smiths Medical
- Smiths Group
Infusion Systems products deliver medication for treating chronic conditions, in hospital and home settings. Smiths Medical is one of the market leaders in ambulatory infusion and have strong positions in the syringe pump market.
Vascular Access products protect healthcare workers and patients from both needlestick injury and hospital-acquired infection.
Vital Care products help manage patient airways before, during and after surgery.
Customers include hospitals, surgery centres, clinics, home care providers and other medical device manufacturers.
The areas of care we specialise in include general anaesthesia, critical care, oncology, cardiology, respiratory care, alternate care, pain management, veterinary, home care, emergency medicine, neonatal and paediatric critical care and regional anaesthesia.
Our solutions include airway management, interventional imaging, IV catheters, safety devices, vascular access, drainage systems, pain management, pressure monitoring, temperature management, ventilation, infusion, patient monitoring, respiratory and tracheostomy.
23 March 2018Interim results for the six months ended 31 January 2018
23 March 2018Smiths Medical announces US launch of the DeltaVen® closed system catheter and FDA clearance
06 December 2017Smiths Group Capital Markets Day